New combo therapy trial aims to restore skin color in vitiligo
NCT ID NCT07251595
Summary
This study is testing whether a new oral tablet called SHR0302, used alone or with a matching SHR0302 gel, can help restore skin color in adults with non-segmental vitiligo. Researchers will measure changes in the size and appearance of white patches on the face and body over 24 weeks. The goal is to see if this treatment is safe and effective at controlling the condition and improving quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SEGMENTAL VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dermatology Hospital affiliated to Shandong First Medical University
RECRUITINGJinan, Shandong, 250022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.